| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bendamustine | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | SN-38 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | UNC0638:navitoclax (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | AZD7762 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.003 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.082 | 0.003 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.003 |